On Monday, Patterson-UTI Energy, Inc. (NASDAQ:PTEN)’s shares inclined 1.19% to $17.92.
PATTERSON-UTI ENERGY, INC. (PTEN) will hold its conference call to talk about results for the second quarter ended June 30, 2015 on Thursday, July 23, 2015 at 9:00 a.m. Central Time.
Patterson-UTI Energy, Inc., through its auxiliaries, provides onshore contract drilling services to major and independent oil and natural gas operators in the United States and Canada. The company operates through three segments: Contract Drilling, Pressure Pumping, and Oil and Natural Gas.
Tesla Motors Inc (NASDAQ:TSLA)’s shares gained 1.16% to $262.16.
Tesla Motors (TSLA) declared 11,507 Model S deliveries for Q2 2015. This was a new company record for the most cars delivered in a quarter and represents an approximate 52% enhance over Q2 last year.
There may be small changes to this delivery count (usually well under 1%), as Tesla only counts a delivery if it is transferred to the end customer and all paperwork is correct.
Also, this is only one measure of our financial performance and should not be relied on as an indicator of our quarterly financial results, which depend on a variety of factors, counting the cost of sales, foreign exchange movements and mix of directly leased vehicles.
Tesla Motors, Inc. designs, develops, manufactures, and sells electric vehicles, electric vehicle powertrain components, and stationary energy storage systems in the United States, China, Norway, and internationally. It also provides development services to develop electric vehicle powertrain components and systems for other automotive manufacturers.
At the end of Monday’s trade, Mastercard Inc (NYSE:MA)‘s shares surged 0.93% to $95.50.
MasterCard Incorporated (MA) will release its second-quarter financial results. The company will host a conference call to talk about these results on Wednesday, July 29, 2015, at 9:00 a.m. Eastern Time.
MasterCard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. The company facilitates the processing of payment transactions, counting authorization, clearing, and settlement, in addition to delivers related products and services. It also offers value-added services, such as loyalty and reward programs, and information and consulting services.
Horizon Pharma PLC (NASDAQ:HZNP), ended its Monday’s trading session with -2.70% loss, and closed at $34.97.
Horizon Pharma PLC (HZNP) pulled back from all-time highs this week, but traders are buying more time for shares to resume their monster rally.
optionMONSTER’s Heat Seeker system detected the sale off 5,000 June 30 calls for $1.40 and the purchase of 5,000 July 32 calls for the ask price of $1.50. Volume was below previous open interest in the near-term contracts, indicating that a long position was rolled forward.
The trader is closing the June contracts, which expire at the end of next week, and paying a net $0.10 to stay in the trade for another month at a higher strike price. The new long calls, which lock in the purchase price of the stock and can provide noteworthy leverage, are looking for shares to rally by expiration in mid-July.
Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
